hologic adult whole body software v. 5.73 (Vertec Scientific Limited)
90
Structured Review
Vertec Scientific Limited
hologic adult whole body software v. 5.73
Hologic Adult Whole Body Software V. 5.73, supplied by Vertec Scientific Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hologic+adult+whole+body+software+v%2E+5%2E73/hologic+adult+whole+body+software+v++5+73/pm17567515-77-50-58
Average 90 stars, based on 1 article reviews
Hologic Adult Whole Body Software V. 5.73, supplied by Vertec Scientific Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hologic+adult+whole+body+software+v%2E+5%2E73/hologic+adult+whole+body+software+v++5+73/pm17567515-77-50-58
Average 90 stars, based on 1 article reviews
hologic adult whole body software v. 5.73 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Fat:Article Title: Evaluation of dirlotapide for sustained weight loss in overweight Labrador retrievers. Article Snippet: The effects of dirlotapide on body weight (BW) reduction were investigated in overweight Labradors in two parallel-design studies.. Study A involved 42 dogs randomized to 0.0, 0.025, 0.05, 0.1, 0.2 or 0.4 mg dirlotapide/kg/day orally for 4 weeks.. Study B involved 72 dogs randomized to nine treatments: placebo (24 weeks); dirlotapide (24 weeks) followed by placebo (28 weeks); or dirlotapide (52 weeks); on diets containing 5%, 10% or 15% fat. Software:Article Title: Evaluation of dirlotapide for sustained weight loss in overweight Labrador retrievers. Article Snippet: The effects of dirlotapide on body weight (BW) reduction were investigated in overweight Labradors in two parallel-design studies.. Study A involved 42 dogs randomized to 0.0, 0.025, 0.05, 0.1, 0.2 or 0.4 mg dirlotapide/kg/day orally for 4 weeks.. Study B involved 72 dogs randomized to nine treatments: placebo (24 weeks); dirlotapide (24 weeks) followed by placebo (28 weeks); or dirlotapide (52 weeks); on diets containing 5%, 10% or 15% fat. |